Health tech gets slammed in new report: Most tech products for people with type 2 diabetes don’t offer meaningful medical benefits, and they cost more than standard care. Digital health startups need to prove their value to stand up to scrutiny.
More docs are charging for email communication: Health insurers are picking up most of the tabs, for now. That could change as subscription healthcare offerings and AI tools become more prevalent.
New uses for hot weight-loss drugs: Wegovy’s potential for preventing heart trouble and treating addiction could expand sales and counter insurers’ reluctance to pay for obesity treatments.
Biotech funding is surging: Investors are clamoring to bet on biotech startups, particularly ones with promising ideas that are already in clinical trials.
Kroger sells specialty pharmacy arm to Elevance’s PBM: Elevance is betting on having more success than Kroger had with the retailer’s specialty pharmacy business.
Google/Fitbit to build an AI-driven personal health coach: Wearable companies are tapping genAI to improve their devices’ health features. We examine the market and assess which companies are best positioned for success.
Hippocratic AI takes aim at nurse tasks: The startup aims to prove its AI is smart and safe enough to replace nurses. It just bagged $53 million, showing the value of a strategy focused on trust and safety.
What’s the 2024 telehealth competitive edge? Consumer demand for virtual care remains strong, per a new Rock Health survey. An influx of telehealth entrants is forcing competition and a slew of value-added services. We dig into the trend.
Basketball star pushes cancer prevention: Marketers are taking advantage of a massive sporting event to promote cancer screenings to consumers.
Contractual dispute between two healthcare giants comes to an end: New York’s Mount Sinai Health System and UnitedHealthcare reached a deal that restores in-network access to care for thousands of patients. But the clash won’t be the last between providers and payers that spills out into the public.
We explore what the partnership means for Lilly, Amazon, and patients.
Change Healthcare’s recent security breach is a harsh reminder of how profitable health data is for cyberattackers.
Young consumers are struggling with finances and social isolation—both of which impact their health. We explore how healthcare providers and marketers can better address social determinants of health.
Consumers most often see healthcare ads on TV: But healthcare and pharma brands must consider other factors—such as which channels patients most trust for health ads—before determining where to allocate their marketing spend.
How a space mission could improve rural health: A miniature surgical robot at the International Space Station successfully performed a simulated procedure. The hope is to someday help ease a surgeon shortage in rural areas.
Google, Nvidia, and Microsoft eye biotech as the real AI moneymaker: Returns are high and AI’s hallucination is a benefit. The ventures could help subsidize the industry’s high costs.
Consumers have different views on public health threats: We examine why marketers must align their messaging to the hot-button health issues top of mind for patients.
HIMSS roundup—Big Tech pushes deeper into healthcare AI: A slew of firms are taking on healthcare AI, but they still need to address a huge challenge—trust.
Apple hypes up Vision Pro for healthcare: It’s getting healthcare apps for surgical assistance, medical education, and more. But most physicians are proceeding with caution—for now.
Microsoft’s demand for AI infrastructure sends Oracle’s shares soaring: Oracle’s affordability and healthcare moves last year, followed by AI investments in 2024, are set to grow its cloud presence.